<DOC>
	<DOCNO>NCT01491919</DOCNO>
	<brief_summary>The drug lisinopril approve U.S. Food Drug Administration treatment high blood pressure , heart failure , acute heart attack adult patient . In child 6 year age , lisinopril approve treatment high blood pressure . Lisinopril group medication call angiotensin-converting enzyme inhibitor ( ACE ) . ACE inhibitor lisinopril work decrease certain chemical tighten blood vessel blood flow smoothly heart pump blood efficiently . There information available child high blood pressure absorb , distribute , metabolize , eliminate lisinopril ( information medication processing body call pharmacokinetic data ) . However , information child high blood pressure receive kidney transplant process lisinopril . In addition decrease blood pressure , investigator believe lisinopril may help kidney transplant work longer reduce activity chemical make cell kidney transplant lead inflammation injury . Such benefit find another group blood pressure medication call calcium channel blocker , commonly used medication group control high blood pressure child kidney transplant . A clinical trial conduct future compare medication group help kidney transplant child last longer . To guide selection best dose test future study , investigator study try determine safety profile , dose tolerability , pharmacokinetics lisinopril child adolescent ( 2-17 year age ) receive kidney transplant high blood pressure .</brief_summary>
	<brief_title>Safety Study Lisinopril Children Adolescents With Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>1 . Kidney transplant recipient 2 . Age 217 year , inclusive , time first study dose 3 . Estimated GFR ( eGFR ) â‰¥30 ml/min/1.73m2 , stable allograft function indicate &lt; 20 % change serum creatinine previous 30 day 4 . Stable immunosuppressive regimen , indicate &lt; 10 % change dosage ( mg/kg ) medication , within 14 day prior enrollment 5 . Systolic BP &gt; 90th percentile age , gender , height , necessitate initiation addition antihypertensive medication 6 . For female childbearing potential , negative serum pregnancy test prior initial dosing agreement practice appropriate contraceptive measure , include abstinence , time initial pregnancy test remainder study ( 30 day last administration investigational agent ) . 1 . History anaphylaxis attributable lisinopril angiotensinconverting enzyme inhibitor ( ACEI ) agent ( e.g. , enalapril , ramipril , quinapril ) 2 . History anaphylaxis attributable iohexol iodine hypersensitivity 3 . Use angiotensinconverting enzyme inhibitor ( ACEI ) , angiotensin receptor blocker , renin antagonist within 30 day prior enrollment 4 . Stage 2 hypertension define &gt; 99th percentile age , height gender + 5 mm Hg 5 . Blood Potassium value &gt; 6.0 milliequivalent / liter ( mEq/L ) ( determine screen visit ) 6 . Previous participation study 7 . Physician concern participant may adhere study protocol , base prior behavior 8 . Current plasmapheresis treatment 9 . History angioedema 10 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>High Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Renal Transplantation</keyword>
	<keyword>Kidney Transplantation</keyword>
</DOC>